News (77)

Update
DateNews
Apr 27, 2017Business Wire - Catabasis Pharmaceuticals to Report First Quarter 2017 Financial Results and Recent Corporate Developments on Thursday, May 11
Apr 25, 2017Business Wire - Catabasis Pharmaceuticals Announces Favorable Results for Functional Assessments in the MoveDMD
Apr 6, 2017PRNewswire All - Pipeline of Duchenne Muscular Dystrophy Market Review Research Covering 21 Major Companies for H1 2017 at ReportsnReports.com
Mar 15, 2017Business Wire - Catabasis Pharmaceuticals to Present at Oppenheimer’s 27
Mar 2, 2017Business Wire - Catabasis Pharmaceuticals to Report Fourth Quarter and Full Year 2016 Financial Results and Recent Corporate Developments on Thursday, March 16
Jan 31, 2017Business Wire - Catabasis Pharmaceuticals Announces Top-Line Results for Part B of the MoveDMD
Nov 10, 2016Business Wire - Catabasis Pharmaceuticals Reports Third Quarter 2016 Financial Results and Recent Corporate Highlights
Nov 3, 2016Business Wire - Catabasis Pharmaceuticals to Host Investor Day in New York City on November 17
Oct 26, 2016Business Wire - Catabasis Pharmaceuticals to Report Third Quarter 2016 Financial Results and Recent Corporate Developments on Thursday, November 10
Oct 25, 2016Business Wire - Non-Profits, Pharmaceutical Companies and Noted Clinicians Collaborate to Launch the Collaborative Trajectory Analysis Project (cTAP); Advancing Clinical Trial Design for Duchenne Muscular Dystrophy
Oct 4, 2016Xconomy - Post FDA Approval, Sarepta Wheels and Deals for Combo Duchenne Drugs
Sep 29, 2016Business Wire - Catabasis Pharmaceuticals Announces Closing of $11.5 Million Offering of Common Stock, Including Full Exercise of Underwriter’s Option to Purchase Additional Shares
Sep 29, 2016Business Wire - Catabasis Pharmaceuticals and Sarepta Therapeutics Announce a Joint Research Collaboration in Duchenne Muscular Dystrophy
Sep 23, 2016Business Wire - Catabasis Pharmaceuticals Announces Pricing of $10 Million Offering of Common Stock
Aug 11, 2016Business Wire - Catabasis Pharmaceuticals Reports Second Quarter 2016 Financial Results and Recent Corporate Highlights
Aug 9, 2016Business Wire - Catabasis Pharmaceuticals to Present at 2016 Wedbush PacGrow Healthcare Conference
Jul 28, 2016Business Wire - Catabasis Pharmaceuticals to Report Second Quarter 2016 Financial Results and Recent Corporate Developments on Thursday, August 11
Jun 14, 2016Business Wire - CureDuchenne and Catabasis Pharmaceuticals to Host a Webinar to Review Information on Edasalonexent (CAT-1004) and the MoveDMD
Jun 10, 2016Xconomy - Biotech Roundup: ASCO, BIO, Drug Setbacks, Incubators & More
Jun 1, 2016PRNewswire UK All - Type 2 Diabetes Market Pipeline Covering 221 Companies for H1 2016 Reviewed in New Research Report